N-Aryl N‘-Hydroxyguanidines, A New Class of NO-Donors after Selective Oxidation by Nitric Oxide Synthases:  Structure−Activity Relationship

Journal of Medicinal Chemistry
2002.0

Abstract

The formation of nitric oxide (NO) was followed during the oxidation of 37 N-hydroxyguanidines or related derivatives, including 18 new N-aryl N'-hydroxyguanidines, by recombinant inducible nitric oxide synthase (NOS II). Several N-aryl N'-hydroxyguanidines bearing a relatively small, electron-donating para subtituent, such as H, F, Cl, CH(3), OH, OCH(3), and NH(2), led to NO formation rates between 8 and 41% of that of NO formation from the natural NOS substrate, N(omega)-hydroxy-L-arginine (NOHA). The characteristics of these reactions were very similar to those previously reported for the oxidation of NOHA by NOS:(i) the strict requirement of NOS containing (6R)-5,6,7,8-tetrahydro-L-biopterin, reduced nicotinamide adenine dinucleotide phosphate, and O(2) for the oxidation to occur, (ii) the formation of NO and the corresponding urea in a 1:1 molar ratio, and (iii) a strong inhibitory effect of the classical NOS inhibitors such as N(omega)-nitro-L-arginine and S-ethyl-iso-thiourea. Structure-activity relationship studies showed that two structural factors are crucial for NO formation from compounds containing a C(triple bond)NOH function. The first one is the presence of a monosubstituted N-hydroxyguanidine function, since disubstituted N-hydroxyguanidines, amidoximes, ketoximes, and aldoximes failed to produce NO. The second one is the presence of a N-phenyl ring bearing a relatively small, not electron-withdrawing para substituent that could favorably interact with a hydrophobic cavity close to the NOS catalytic site. The k(cat) value for NOS II-catalyzed oxidation of N-para-fluorophenyl N'-hydroxyguanidine was 80% of that found for NOHA, and its k(cat)/K(m) value was only 9-fold lower than that of NOHA. Interestingly, the K(m) value found for NOS II-catalyzed oxidation of N-(3-thienyl) N'-hydroxyguanidine was 25 microM, almost identical to that of NOHA. Recombinant NOS I and NOS III also oxidize several N-aryl N'-hydroxyguanidines with the formation of NO, with a clearly different substrate specificity. The best substrates of the studied series for NOS I and NOS III were N-(para-hydroxyphenyl) and N-(meta-aminophenyl) N'-hydroxyguanidine, respectively. Among the studied compounds, the para-chlorophenyl and para-methylphenyl derivatives were selective substrates of NOS II. These results open the way toward a new class of selective NO donors after in situ oxidation by each NOS family.

Knowledge Graph

Similar Paper

N-Aryl N‘-Hydroxyguanidines, A New Class of NO-Donors after Selective Oxidation by Nitric Oxide Synthases:  Structure−Activity Relationship
Journal of Medicinal Chemistry 2002.0
Oxidation of N<sup>ω</sup>-Hydroxyarginine Analogues by NO-Synthase: The Simple, Non Amino Acid N-Butyl N‘-Hydroxyguanidine Is Almost as Efficient an NO Precursor as N<sup>ω</sup>-Hydroxyarginine
Journal of Medicinal Chemistry 2001.0
Isoform-Selective Substrates of Nitric Oxide Synthase
Journal of Medicinal Chemistry 2003.0
N-Hydroxyl derivatives of guanidine based drugs as enzymatic NO donors
Bioorganic &amp; Medicinal Chemistry Letters 2001.0
Electrochemical and peroxidase oxidation study of N′-Hydroxyguanidine derivatives as NO donors
Bioorganic &amp; Medicinal Chemistry Letters 2002.0
Examination of N -hydroxylation as a prerequisite mechanism of nitric oxide synthase inactivation
Bioorganic &amp; Medicinal Chemistry Letters 2000.0
Hydroxyurea Analogues As Kinetic and Mechanistic Probes of the Nitric Oxide Producing Reactions of Hydroxyurea and Oxyhemoglobin
Journal of Medicinal Chemistry 2003.0
N<sup>G</sup>-Aminoguanidines from Primary Amines and the Preparation of Nitric Oxide Synthase Inhibitors
Journal of Medicinal Chemistry 2008.0
Guanidine-substituted imidazoles as inhibitors of nitric oxide synthase
Bioorganic &amp; Medicinal Chemistry Letters 1999.0
Acyloxy Nitroso Compounds as Nitroxyl (HNO) Donors: Kinetics, Reactions with Thiols, and Vasodilation Properties
Journal of Medicinal Chemistry 2011.0